Expression of heat shock protein gp96 in osteosarcoma and its clinical significance

Expression of heat shock protein gp96 in osteosarcoma and its clinical significance

Abstract

This study aims to detect the expression of heat shock protein gp96 (HSPgp96) in osteosarcoma and explore its role in anti-tumor immunity. Expression of HSPgp96 in 45 cases of osteosarcoma, including 24 cases of the osteoblast type, 21 cases of chondroblast type and 5 cases of normal bone tissue were detected by immunohistochemistry (IHC). The expression rate of HSPgp96 was 100% (45/45) in osteosarcoma, compared with 20% (1/5) in normal bone tissue. The average positive cell rates were 97.23% and 0.48% in osteosarcoma and normal bone tissue, respectively, and the difference between them was significant (P < 0.01). The positive cell rates in osteoblast type and chondroblast type were 97.78% and 96.56%, respectively, and the difference had no statistical significance (P > 0.05). The expression degree of HSPgp96 in osteosarcoma had a clear correlation with the pathologic degree (P < 0.05), while it had no relationship with the clinical stage (P > 0.05). The expression of HSPgp96 is high in osteosarcoma and it may be a significant index for judgment of malignancy degree and an important target site of anti-tumor immunity.

参考文献

1. Théoleyre S Mori K Cherrier B Passuti N Gouin F Rédini F Heymann D Phenotypic and functional analysisof lymphocytes infiltrating osteolytic tumors: use as a possible therapeuticapproach of osteosarcomaBMC Cancer 2005 5123. doi: 10.1186/1471‐2407‐5‐123
2. Link M P Goorin A M Horowitz M Meyer W H Belasco J Baker A Ayala A Shuster J Adjuvant chemotherapy of high-grade osteosarcoma of theextremity. Updated results of the multi-institutional osteosarcomastudyClin Orthop Relat Res 1991 (270)814
3. Provisor A J Ettinger L J Nachman J B Krailo M D Makley J T Yunis E J Huvos A G Betcher D L Baum E S Kisker C T Miser J S Treatmentof non-metastatic osteosarcoma of the extremity with pre-operativechemotherapy: a report from the Children's Cancer GroupJ Clin Oncol 1997 15(1)7684
4. Binder R J Kelly J B Vatner R F Srivastava P K SpecificImmunogenicity of Heat Shock Protein gp96 Derives from ChaperonedAntigenic Peptides and Not from Contaminating ProteinsJ Immunol 2007 1179(11)72547261
5. Podack E R Raez L E Allogeneic tumor-cell-basedvaccines secreting endoplasmic reticulum chaperone gp96Expert Opin Biol Ther 2007 7(11)16791688. doi:10.1517/14712598.7.11.1679
6. Amato R J Heat-shockprotein-peptide complex-96 for the treatment of cancerExpert Opin Biol Ther 2007 7(8)12671273. doi:10.1517/14712598.7.8.1267
7. Srivastava P K Menoret A Basu S Binder R J McQuade K L Heat shock proteins come of age: primitivefunctions acquire new roles in an adaptive worldImmunity 1998 8(6)657665. doi:10.1016/S1074‐7613(00)80570‐1
8. Altmeyer A Maki R G Feldweg A M Heike M Protopov V P Masur S K Srivastava P K Tumor-specific cell surfaceexpression of KDEL-containing, endoplasmic reticular heat shock proteingp96Int J Cancer 1996 69(4)340349. doi:10.1002/(SICI)1097‐0215(19960822)69:4<340::AID‐IJC18>3.0.CO;2‐9
9. Robert J Menoret A Cohen N Cell surface expression of the endoplasm micreticular heatshock protein gp96 is phylogenetically conservedJ Immunol 1999 163(8)41334139
10. Kimura E Enns R E Alcaraz J E Alboleda J Slamon D J Howell S B Correlationof the survival of ovarian cancer patients with mRN A expression ofthe 60-kD heat-shock protein HSP-60J ClinOncol 1993 11(5)891898
11. Ullrich S J Robinson E A Law L W Willingham M Appella E A mouse tumor-specific transplantationantigen is a heat shock-related proteinProc Natl Acad Sci USA 1986 83(10)31213125. doi:10.1073/pnas.83.10.3121
12. Xu X F Shi Y J Tang P Z Heat shock protein and tumorGuo Wai Yi Xue Er Bi Yan Hou Ke Fen Ce 1998 2225(in Chinese)
13. Young R A Stressproteins and immunologyAnnu Rev Immunol 1990 8401. doi: 10.1146/annurev.iy.08.040190.002153
14. Melcher A Todryk S Hardwick N Ford M Jacobson M Vile R G Tumorimmunogenicity is determined by mechanism of cell death via inductionof heat shock protein expressionNat Med 1998 4(5)581587. doi:10.1038/nm0598‐581
15. Suto R Srivastava P K A mechanism for the specificimmunogenicity of heat shock protein-chaperoned peptidesScience 1995 269(5230)15851588. doi:10.1126/science.7545313
16. Qu J L Xu H M Yan Y Expression and Detection of Chaperone Proteins in HumanGastric CancerShi Jie Hua Ren Xiao HuaZa Zhi 2005 13(15)18091813(in Chinese)
17. Trieb K Lang S Kotz R Heat-shock protein 72 in human osteosarcoma: T-lymphocytesreactivity and cytotoxicityPediatr HematolOncol 2000 17(5)355364. doi:10.1080/08880010050034283